Currently in India the population of people suffering from lung cancer is increasing at an alarming rate. Chemotherapy is widely used for the management of lung cancer; however it has various side effects. Hence, there is a need to find newer therapeutic agents with fewer side effects. Plant derived substances are generally considered as the most preferred alternative medicines. Thus, in this study, we have tested the antiproliferative property of Cleistanthin-A, a chemical compound extracted from dried leaves of Cleistanthus collinus, against the A549 lung cancer cell lines. The antiproliferative assays used are dye exclusion assay, MTT assay and Comet assay.
INTRODUCTION
Changing lifestyles, urbanization, globalization and progressive control of communicable diseases have led to emergence of cancer and other non communicable diseases as an important health problem in India. The environmental risk factors for lung cancer are carcinogen and co-carcinogen which are present in tobacco and its related products 1 . Cigarettes are the most important tobacco product worldwide (http:/ /tobaccopedia.org). It is estimated that cancer incidence would increase to 1,869,983 (1.87 million) by the year 2026. The International agency for research on cancer called as Globocan project has predicted that in India patients with cancer by 2035 will be nearly 1.7 billion 2 . In India, approximately 63,000 new lung cancer cases are reported each year 3 . Apart from tobacco related products, other causative agents for lung cancer are radon gas, asbestos, silica, and diesel exhaust, excess exposure to air pollution, chronic lung infection like tuberculosis (www. Cancer research uk.org /about -cancer /type /lung-cancer/ about/ lung-cancer-risks-and-causes). Tobacco smokers above age 50 years are at high risk for lung cancer 4 . Lung cancer is also a hereditary disease 5 . In nonsmokers, the etiology of lung cancer is due to the environmental, hormonal, genetic and viral implications (6) . Reactive oxygen species (ROS) are recognized to play a dual role in both regulation of physiological reactions and also leading to oxidative stress which generates a negative bioniche for the generation of chronic diseases like cancer 7 . Antioxidants like vitamins-A, C and E were thought to help reduce the risk of lung cancer, but evidence for this is not clear (www. cancerresearchuk.org/about-cancer/type/lungcancer/about/lung-cancer-risks-and-causes).
A549 cell line is alveolar basal epithelial cells. A549 cell lines are widely used as an in vitro model for a type II pulmonary epithelial cell model for drug metabolism and as a transfection host [8] [9] . The mRNA of nicotinic acetylcholine receptor á7 is expressed in all the human cancer cell lines 10 . nAChR genes are expressed in both in neuronal cells and also in other non-neuronal tissue cells like skin, pancreas and lung. Through this it is evident that nAChRs can play vital role in other biological processes in addition to synaptic transmission [11] [12] . Nicotine result in influx of calcium ions into lung cancer cells as the result of it's binding to á7nAChR and thus causes membrane depolarization which in turns activates the MAPK pathway, which may result in the elevated expression of B-cell lymphoma-2 protein, thus down-regulating apoptosis of such cells 13 .
In the present work, the Cleistanthin-A fraction extracted from the dried leaf of poisonous plant Cleistanthus collinus (Oduvanthalai in Tamil) (unpublished), was used as an anti-proliferative agent, to inhibit the proliferation of A549 cell line. It is interesting that this toxin also has curative properties. Extract of various plant parts yielded a multitude of compounds of which the glycosides, arylnaphthalene lignan lactones are toxic 14 . These lignan lactones include Cleistanthin-A and B 15 , collinusin and diphyllin. Mortality is attributed to cardiac arrhythmias1, 4 acute renal failure, shock and respiratory failure in humans.
METHODOLOGY Compound Isolation
Cleistanthin-A, the active principle of the plant Cleistanthus collinus, was isolated using a novel method established by the department of Physiology, Christian Medical College, Vellore (Unpublished). This isolated compound was characterized initially by thin layer chromatography profiling followed by UV & FT-IR and the antioxidant property by DPPH activity was analysed 16 .
Sample used 1mg of the Cleistanthin-A was suspended in 1ml of DMSO and 1:3 dilution was prepared for the MTT assay 17 .
Maintenance of A549 cell line A549 cell lines were obtained from National centre for cell sciences, Pune (NCCS). The cells were maintained in MEM supplemented with 3.75 gms sodium hydrogen carbonate, 10% FBS, penicillin (100 U/ml), and streptomycin (100 ìg/ml) in a humidified atmosphere of 5% CO 2 at 37 °C 18 .
After the monolayer has established after four days of incubation, the cells were subjected to trypsinisation (0.25% trypsin and 1mM EDTA in .
Trypan blue dye exclusion test
The cells were rinsed with DPBS, to remove trypsin if any. Then the cells were suspended in sterile DPBS. 0.4% of trypan blue dye was added to the cell suspension. 20ìl of cell suspension was loaded onto a hemocytometer and cell count was performed. Viable cells would have excluded trypan blue and the total viable cells were recorded. MTT assay was further performed for the confirmation of the viability 19 .
Cell viability assay
The anticancer activity of Cleistanthin-A on Lung cancer cell line (A549) was determined by the MTT assay (20) . Cells (1 × 10 5 /well) were plated in 0.2 ml of medium/well in 96-well plates and cultured in a 5 % CO 2 incubator at 37°C for 72 hours. Various concentrations of Cleistanthin-A in 0.1% DMSO were then added and the cells cultured for a further 24hrs. The supernatant was removed and 20ìl/well (5mg/ml) of 0.5% 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-tetrazolium bromide (MTT) in phosphate-buffered saline solution was added to all the wells. After 4hrs incubation, 1ml of Dimethyl Sulfoxide (DMSO) was added. The contents of the well were transferred to a fresh sterile 1.5 ml microfuge and were subjected to centrifugation at 18°C for 1500 rpm, to remove the cell debris. Viable cells were determined by the absorbance at 540nm. Measurements were performed and the concentration required for a 50% inhibition of viability (IC 50 ) was determined graphically. The effect of the samples on the proliferation of A549 cells was expressed as the % cell viability, using the following formula: % cell viability = A 540 of treated cells / A 540 of control cells × 100
Comet Assay
Comet assay was performed [21] [22] . About 1x10 5 cell of A549 were seeded in 24-well tissue culture plates and after 24 hours of incubation at 37°C and in 5% CO 2 humified atmosphere, various concentration of Cleistanthin-A suspended in DMSO cells and the untreated control cells were analysed for the comet tail length, which confirms the DNA degradation patterns.
RESULT
After the A549 cells were cultured in MEM medium, for all the following analysis the cell concentration of 1x10 5 / well of cells were used. The trypan blue dye exclusion test, demonstrated 80% cell viability. Cleistanthin-A reduced the number of viable cells which is evident through the MTT assay ( Figure.1 ). At 100 ìg/ml concentration of Cleistanthin-A, all cells were killed. IC 50 concentration of the Cleistanthin-A suspended in DMSO was determined graphically as 6.25 ìg/ml for the, lung cancer line (Table. 1 and Graph.1). All the experiments were performed in triplicates and the graph was generated by using Microsoft excel 2007 edition.
DISCUSSION
Currently even though variety of chemotherapeutics available for lung cancer, there is need for newer drugs with less toxicity 23 . Nicotine can induce the activation of NF-êB through the MAP kinase and PI3K/AKT signaling pathways, which promote survival, proliferation, and angiogenesis of endothelial cells 24 . The current chemotherapy either in combined form or in individual forms are not successful 25 . Hence this current investigation could pave way for developing suitable therapy for lung cancer. Thus the A549 cell line was chosen as the suitable model to study the effectiveness of Cleistanthin-A as an antiproliferative compound.
Graph 1: IC 50 value
The compound Cleistanthin-A has a good antioxidant property. These could be the suitable reasons for the compound Cleistanthin-A contributing to the antiproliferative property against the A549 cell line. Further in silico studies of Cleistanthin-A binding effectively to nAChRs receptors was also studied by patch dock 26 . Further studies must elucidated in relation to the analyses of pharmacokinetics and pharmacodynamics to confirm the role of Cleistanthin-A as a good anticancer drug for lung cancer in case of both nonsmokers and smokers.
CONCLUSION
In this present study it is evident that Cleistanthin -A can reduce viability of A549 cell line, a lung cancerous cell line model.
